Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors tested whether clonidine blocks stress-induced seeking of heroin and cocaine. The study was also intended to confirm translational findings from a rat model of drug relapse by using ecological momentary assessment of patients' stress to test hypotheses about clonidine's behavioral mechanism of action. METHOD: The authors conducted a randomized double-blind placebo-controlled clinical trial with 208 opioid-dependent patients at an outpatient buprenorphine clinic. The 118 participants (57%) who maintained abstinence during weeks 5-6 were continued on buprenorphine and randomly assigned to receive clonidine (N=61) or placebo (N=57) for 14 weeks. Urine was tested thrice weekly. Lapse was defined as any opioid-positive or missed urine test, and relapse as two or more consecutive lapses. Time to lapse and relapse were examined with Cox regressions; longest period of abstinence was examined with a t test, and ecological momentary assessment data were examined with generalized linear mixed models. RESULTS: In an intent-to-treat analysis, clonidine produced the longest duration (in consecutive days) of abstinence from opioids during the intervention phase (34.8 days [SD=3.7] compared with 25.5 days [SD=2.7]; Cohen's d=0.38). There was no group difference in time to relapse, but the clonidine group took longer to lapse (hazard ratio=0.67, 95% CI=0.45-1.00). Ecological momentary assessment showed that daily-life stress was partly decoupled from opioid craving in the clonidine group, supporting the authors' hypothesized mechanism for clonidine's benefits. CONCLUSIONS: Clonidine, a readily available medication, is useful in opioid dependence not just for reduction of withdrawal signs, but also as an adjunctive maintenance treatment that increases duration of abstinence. Even in the absence of physical withdrawal, it decouples stress from craving in everyday life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The EMA data we collected during our clonidine trial (Kowalczyk et al. 2015) provided mechanistic insight we could not otherwise have had, showing that clonidine seemed to act by decoupling stress from craving.”
From Context and craving during stressful events in the daily lives of drug-dependent patients (2017) · cites this paper as Kowalczyk et al. 2015
In the citing paper
“led our research clinic to conduct a randomized clinical trial that found that clonidine increased time to lapse and longest duration of abstinence during treatment for heroin addiction (Kowalczyk et al. 2015).”
From Context and craving during stressful events in the daily lives of drug-dependent patients (2017) · cites this paper as Kowalczyk et al. 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757
Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors
Washton, A. M. (1986) · Journal of Studies on Alcohol · doi:10.15288/jsa.1986.47.260 · Cited by 2,527
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615 · cited 1×
“In searchof such a treatment,we turned tofindings from the rat reinstatement model, in which extinguished drug seeking resumes after exposure to a stressor, a drug cue, or a priming dose of drug (7, 8).”
New Data from the Addiction Severity Index Reliability and Validity in Three Centers
McLELLAN, A. T., LUBORSKY, L., CACCIOLA, J., GRIFFITH, J., EVANS, F., BARR, H. L., & OʼBRIEN, C. P. (1985) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198507000-00005 · Cited by 1,503 · cited 1×
“Study candidates were evaluated with standardized interviews (30, 31), physical examination, and laboratory screenings.”
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880 · cited 1×
“First, we took a literal approach to relapse prevention: we randomized participants to clonidine or placebo only after they had achieved a period of outpatient abstinence from opioids, because cessation of ongoing drug use is probably mediated by neural processes different from those involved in avoidance of relapse (…”
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461
Bossert, J. M., Marchant, N. J., Calu, D. J., & Shaham, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3120-y · Cited by 453
Immediate antecedents of cigarette smoking: An analysis from ecological momentary assessment.
Shiffman, S., Gwaltney, C. J., Balabanis, M. H., Liu, K. S., Paty, J. A., Kassel, J. D., Hickcox, M., & Gnys, M. (2002) · Journal of Abnormal Psychology · doi:10.1037//0021-843x.111.4.531 · Cited by 405 · cited 1×
“Second, to address mechanistic questions about whether clonidine would prevent only certain types of relapses, we incorporated ecological momentary assessment, a method of collecting field data with handheld computers on which participants report, in real time, their activities and moods (27).”
Lachin, J. M., & Foulkes, M. A. (1986) · Biometrics · doi:10.2307/2531201 · Cited by 400 · cited 1×
“Power analyses indicated a required sample size of 120 (32).”
Remember that? A comparison of real-time versus retrospective recall of smoking lapses.
Shiffman, S., Hufford, M., Hickcox, M., & Paty, J. A. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.2.292.a · Cited by 379 · cited 1×
“Ecological momentary assessment is essential for addressing questions about the order in which events happen and the extent to which one event is specifically associated with another (5); retrospective assessments of the same questions are fraught with illusory correlations that result from recall biases (28, 29).”
Retrospective and Concurrent Self-Reports: The Rationale for Real-Time Data Capture
Schwarz, N. (2007) · The Science of Real-Time Data Capture · doi:10.1093/oso/9780195178715.003.0002 · Cited by 373
Epstein, D. H., Willner-Reid, J., Vahabzadeh, M., Mezghanni, M., Lin, J.-L., & Preston, K. L. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.509 · Cited by 300 · cited 3×
“Ecological momentary assessment is essential for addressing questions about the order in which events happen and the extent to which one event is specifically associated with another (5); retrospective assessments of the same questions are fraught with illusory correlations that result from recall biases (28, 29).”
Self-citationAlpha-2 Adrenergic Receptor Agonists Block Stress-Induced Reinstatement of Cocaine Seeking
Erb, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00158-x · Cited by 270 · cited 2×
“As we discussed, reinstatement studies in rodents and human laboratory studies have shown that alpha-2 adrenoceptor agonists can block drug seeking and craving induced by stress (9–11, 15) and possibly by drug cues (14–16, 18), but not by priming doses of drug (9).”
L�, A. D., Harding, S., Juzytsch, W., Funk, D., & Shaham, Y. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2036-y · Cited by 255
Translational and reverse translational research on the role of stress in drug craving and relapse
Sinha, R., Shaham, Y., & Heilig, M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2263-y · Cited by 208
Shaham, Y., Highfield, D., Delfs, J., Leung, S., & Stewart, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00899.x · Cited by 201
Effects of adding behavioral treatment to opioid detoxification with buprenorphine.
Bickel, W. K., Amass, L., Higgins, S. T., Badger, G. J., & Esch, R. A. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.65.5.803 · Cited by 199
(1979) · American Journal of Psychiatry · doi:10.1176/ajp.136.1.100 · Cited by 189 · cited 1×
“This would be a new treatment approach with clonidine, unrelated to its well-established use as an adjunctive medication during opioid detoxification (23, 24).”
Initial abstinence and success in achieving longer term cocaine abstinence.
Higgins, S. T., Badger, G. J., & Budney, A. J. (2000) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.8.3.377 · Cited by 186 · cited 1×
“The clinical benefit of delaying initial lapses seems clear in the context of findings that “abstinence begets abstinence” (33)—in other words, that the longer the duration of abstinence, the greater the likelihood that it will be sustained.”
Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.
Silverman, K., Wong, C. J., Umbricht, A., Montoya, I. D., Schuster, C. R., & Preston, K. L. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.66.5.811 · Cited by 178
Self-citationEffects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse
Haney, M., Hart, C. L., Vosburg, S. K., Comer, S. D., Reed, S. C., & Foltin, R. W. (2008) · Psychopharmacology · doi:10.1007/s00213-007-1020-8 · Cited by 174
Kosten, T. R., Oliveto, A. H., Feingold, A., Poling, J. C., Sevarino, K. A., McCance‐Katz, E. F., Stine, S. M., Gonzalez, G. M., & Gonsai, K. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00032-2 · Cited by 134
Clonidine and the treatment of the opiate withdrawal syndrome
Gossop, M. (1988) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(88)90078-6 · Cited by 131 · cited 1×
“This would be a new treatment approach with clonidine, unrelated to its well-established use as an adjunctive medication during opioid detoxification (23, 24).”
Opioid Detoxification and Naltrexone Induction Strategies: Recommendations for Clinical Practice
Sigmon, S. C., Bisaga, A., Nunes, E. V., O'Connor, P. G., Kosten, T., & Woody, G. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.653426 · Cited by 127 · cited 1×
“Clonidine is especially appealing because it carries no special prescribing requirements like those imposed on buprenorphine and methadone, and it is known to be well tolerated in opioid users because it is used regularly for short-term amelioration of withdrawal signs (35).”
Sinha, R., Kimmerling, A., Doebrick, C., & Kosten, T. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0640-8 · Cited by 127
Shiffman, S., Ferguson, S. G., & Gwaltney, C. J. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0175-4 · Cited by 114
Fox, H. C., Seo, D., Tuit, K., Hansen, J., Kimmerling, A., Morgan, P. T., & Sinha, R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111430746 · Cited by 112
Sorge, R. E., Rajabi, H., & Stewart, J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300712 · Cited by 90 · cited 2×
“Both groups inour trialwere presumably somewhat protected from priming effects, because buprenorphine maintenance confers that protection (21).”
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1 · Cited by 90
Highfield, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00227-5 · Cited by 81
Leri, F., Tremblay, A., Sorge, R. E., & Stewart, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300435 · Cited by 80
Clonidine blocks stress-induced craving in cocaine users
Jobes, M. L., Ghitza, U. E., Epstein, D. H., Phillips, K. A., Heishman, S. J., & Preston, K. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2230-7 · Cited by 78
Self-citationYamada, H., & Bruijnzeel, A. W. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.09.013 · Cited by 74
α2 Adrenergic and Imidazoline Receptor Agonists Prevent Cue-Induced Cocaine Seeking
Smith, R. J., & Aston-Jones, G. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.010 · Cited by 69
Fox, H., & Sinha, R. (2014) · Advances in Pharmacology · doi:10.1016/b978-0-12-420118-7.00006-8 · Cited by 46
Making a Structured Psychiatric Diagnostic Interview Faithful to the Nomenclature
Robins, L. N., & Cottler, L. B. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh283 · Cited by 32 · cited 1×
“Study candidates were evaluated with standardized interviews (30, 31), physical examination, and laboratory screenings.”
Bidirectional translational research: Progress in understanding addictive diseases
Kreek, M. J., Schlussman, S. D., Reed, B., Zhang, Y., Nielsen, D. A., Levran, O., Zhou, Y., & Butelman, E. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.042 · Cited by 28
Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes
Ferguson, S. G., & Shiffman, S. S. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3429-6 · Cited by 27
Effect of high-dose nicotine patch on the characteristics of lapse episodes.
Ferguson, S. G., & Shiffman, S. S. (2010) · Health Psychology · doi:10.1037/a0019367 · Cited by 25
Shiffman, S., & Ferguson, S. G. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802380341 · Cited by 22
Cited by
Treatment of opioid-use disorders
Schuckit, M. A. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1604339 · Cited by 540
“Data are from Kowalczyk et al.21 and Gowing et al.22 ‡ Doses are approximate.”
MethodStress-induced reinstatement of drug seeking: 20 years of progress
Mantsch, J. R., Baker, D. A., Funk, D., Lê, A. D., & Shaham, Y. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.142 · Cited by 438
Time to connect: bringing social context into addiction neuroscience
Heilig, M., Epstein, D. H., Nader, M. A., & Shaham, Y. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.67 · Cited by 298
Self-citationPergolizzi, J. V., Raffa, R. B., & Rosenblatt, M. H. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13114 · Cited by 229
Improving translation of animal models of addiction and relapse by reverse translation
Venniro, M., Banks, M. L., Heilig, M., Epstein, D. H., & Shaham, Y. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0378-z · Cited by 212
Self-citation
Metadata
- Authors
- Kowalczyk, W. J., Phillips, K. A., Jobes, M. L., Kennedy, A. P., Ghitza, U. E., Agage, D. A., Schmittner, J. P., Epstein, D. H., & Preston, K. L.
- Affiliations
- National Institutes of Health (US)
- Venue
- American Journal of Psychiatry
- Published
- 2015-08-01
- Volume
- 172
- Issue
- 8
- Pages
- 760-767
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC6233893
- OpenAlex
- W2127186356
- Cited by
- 101
- References
- 40
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 10 · 2023: 7 · 2022: 6 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 17 · 2017: 7 · 2016: 10 · 2015: 4
- FWCI
- 13.55
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse (Z01DA000175)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- clonidine, opioid use disorder, opioid relapse, opioid abstinence, stress, opioid craving, buprenorphine maintenance, adjunctive pharmacotherapy, heroin, cocaine, daily stress
- MeSH terms
- Adult, Analgesics, Buprenorphine, Clonidine, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Narcotic Antagonists, Opioid-Related Disorders, Substance Withdrawal Syndrome, Proportional Hazards Models, Treatment Outcome, Opiate Substitution Treatment, Maintenance Chemotherapy, Craving
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.